Prothena Corp. PLC Co-Founder, President and CEO Dale Schenk, a protein immunotherapy pioneer, died on Sept. 30 from pancreatic cancer that he revealed publicly less than two years ago.
Prothena CEO Dale Schenck Dies From Pancreatic Cancer
Prothena CEO Dale Schenk, the scientist behind innovative medicines that included bapineuzumab and Tysabri, died from pancreatic cancer on Sept. 30 – less than two years after he revealed his diagnosis.